Anti-Neurotrypsin 抗体 - Catalytic domain (ab59454)


  • 製品名Anti-Neurotrypsin antibody - Catalytic domain
  • 製品の詳細
    Rabbit polyclonal to Neurotrypsin - Catalytic domain
  • 特異性Recognizes the 875 and 834 amino acid forms of neurotrypsin. We have a range of domain specific antibodies for this target. For a full list please see all Neurotrypsin antibodies.
  • アプリケーション適用あり: IHC-Fr, WBmore details
  • 種交差性
    交差種: Mouse, Rat, Human
  • 免疫原

    Synthetic peptide based on the catalytic domain of human Neurotrypsin.


  • 製品の状態Liquid
  • 保存方法Shipped at 4°C. Store at -20°C. Stable for 12 months at -20°C.
  • バッファーPreservative: 0.05% Sodium Azide
    Constituents: 50% Glycerol, PBS, 500mM Sodium chloride, pH 7.4
  • Concentration information loading...
  • 精製度Immunogen affinity purified
  • ポリ/モノポリクローナル
  • アイソタイプIgG
  • 研究分野


Our Abpromise guarantee covers the use of ab59454 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
IHC-Fr Use at an assay dependent concentration.
WB Use at an assay dependent concentration. Predicted molecular weight: 97 kDa. A recommended starting concentration for Western blots is 1/1000 when using colorimetric substrates such as BCIP/NBT and 1/5000 for chemiluminescent substrates.


  • 機能Plays a role in neuronal plasticity and the proteolytic action may subserve structural reorganizations associated with learning and memory operations.
  • 組織特異性Brain and Leydig cells of the testis.
  • 関連疾患Defects in PRSS12 are the cause of mental retardation autosomal recessive type 1 (MRT1) [MIM:249500]. Mental retardation is a mental disorder characterized by significantly sub-average general intellectual functioning associated with impairments in adaptative behavior and manifested during the developmental period. Non-syndromic mental retardation patients do not manifest other clinical signs.
  • 配列類似性Belongs to the peptidase S1 family.
    Contains 1 kringle domain.
    Contains 1 peptidase S1 domain.
    Contains 4 SRCR domains.
  • 細胞内局在Secreted.
  • Information by UniProt
  • 参照データベース
  • 別名
    • BSSP 3 antibody
    • BSSP3 antibody
    • Leydin antibody
    • MGC12722 antibody
    • Motopsin antibody
    • MRT1 antibody
    • NETR_HUMAN antibody
    • Neurotrypsin antibody
    • protease, serine, 12 (neurotrypsin, motopsin) antibody
    • Prss12 antibody
    • Serine protease 12 antibody
    see all

Anti-Neurotrypsin antibody - Catalytic domain 画像

  • All lanes : Anti-Neurotrypsin antibody - Catalytic domain (ab59454) at 1/1000 dilution

    Lane 1 : Tissue lysate prepared from rat testis at 15 µl
    Lane 2 : Tissue lysate prepared from rat testis at 10 µl
    Lane 3 : Tissue lysate prepared from mouse testis at 10 µl
    Lane 4 : Tissue lysate prepared from mouse testis at 8 µl
    Lane 5 : Tissue lysate prepared from mouse testis at 6 µl

    Predicted band size : 97 kDa

Anti-Neurotrypsin antibody - Catalytic domain (ab59454) 使用論文

This product has been referenced in:
  • Meliopoulos VA  et al. MicroRNA regulation of human protease genes essential for influenza virus replication. PLoS One 7:e37169 (2012). WB ; Human . Read more (PubMed: 22606348) »

See 1 Publication for this product

Product Wall

Application Immunohistochemistry (PFA perfusion fixed frozen sections)
Antigen retrieval step None
Sample Mouse Tissue sections (brain hemisphere coronal sections)
Specification brain hemisphere coronal sections
Blocking step Serum as blocking agent for 30 minute(s) · Concentration: 2 · Temperature: 25°C
Fixative Paraformaldehyde

Abcam user community

Verified customer

投稿 Jul 15 2013

Thank you very much for your interest our AbTrial program.

To our knowledge, ab59454 has not been tested in IHC-p or IHC-Fr. However by participating in our AbTrial program you can now use our products in an untested application or species w...

Read More

According to our records, ab50454 was proving difficult to use inWestern blotand we were in contact in order to help resolve the issue. Looking at our correspondence, it appears that we are awaiting more details in order to help us better understand th...

Read More

Thank you for contacting us and letting us know about the trouble with this antibody. I do have a couple of additional questions so that I can better understand the situation. Did you also probe for a loading control like beta actin? What is the differ...

Read More